Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Helsing

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical Epidemiology|May 22, 2018
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registryTrude Eid Robsahm, Per Helsing, Yngvar Nilssen, et al.
Contact Dermatitis|June 12, 2010
Variability in patch test reactions--first report from the Norwegian Patch Test RegistryPer Helsing, Petter Gjersvik, Jan-Øivind Holm, et al.
Acta Dermato-Venereologica|May 16, 2024
Clinical versus Histological Assessment of Basal Cell Carcinoma Subtype and Thickness of Tumours Selected for Photodynamic TherapyErik Mørk, Patricia Mjønes, Olav A Foss, et al.
JAMA Dermatology|October 20, 2017
Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort StudySyed Mohammad Husain Rizvi, Bjarte Aagnes, Hallvard Holdaas, et al.
Plos One|March 8, 2024
New, simplified versus standard photodynamic therapy (PDT) regimen for superficial and nodular basal cell carcinoma (BCC): A single-blind, non-inferiority, randomised controlled multicentre studyEidi Christensen, Erik Mørk, Olav Andreas Foss, et al.
Genes, Chromosomes & Cancer|November 21, 2007
Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomasPer Helsing, Dag Andre Nymoen, Sarah Ariansen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 1, 2013
Malignant melanoma--diagnosis, treatment and follow-up in NorwayJürgen Geisler, Ingeborg M Bachmann, Marta Nyakas, et al.
The Journal of Investigative Dermatology|June 3, 2016
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip ProjectElena Tagliabue, Sara Gandini, José C García-Borrón, et al.
BMC Medical Research Methodology|August 7, 2012
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studiesSara Raimondi, Sara Gandini, Maria Concetta Fargnoli, et al.
International Journal of Cancer|August 1, 2014
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regionsJennifer H Barrett, John C Taylor, Chloe Bright, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Epidemiology|May 22, 2018
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registryTrude Eid Robsahm, Per Helsing, Yngvar Nilssen, et al.
Contact Dermatitis|June 12, 2010
Variability in patch test reactions--first report from the Norwegian Patch Test RegistryPer Helsing, Petter Gjersvik, Jan-Øivind Holm, et al.
Acta Dermato-Venereologica|May 16, 2024
Clinical versus Histological Assessment of Basal Cell Carcinoma Subtype and Thickness of Tumours Selected for Photodynamic TherapyErik Mørk, Patricia Mjønes, Olav A Foss, et al.
JAMA Dermatology|October 20, 2017
Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort StudySyed Mohammad Husain Rizvi, Bjarte Aagnes, Hallvard Holdaas, et al.
Plos One|March 8, 2024
New, simplified versus standard photodynamic therapy (PDT) regimen for superficial and nodular basal cell carcinoma (BCC): A single-blind, non-inferiority, randomised controlled multicentre studyEidi Christensen, Erik Mørk, Olav Andreas Foss, et al.
Genes, Chromosomes & Cancer|November 21, 2007
Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomasPer Helsing, Dag Andre Nymoen, Sarah Ariansen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 1, 2013
Malignant melanoma--diagnosis, treatment and follow-up in NorwayJürgen Geisler, Ingeborg M Bachmann, Marta Nyakas, et al.
The Journal of Investigative Dermatology|June 3, 2016
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip ProjectElena Tagliabue, Sara Gandini, José C García-Borrón, et al.
BMC Medical Research Methodology|August 7, 2012
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studiesSara Raimondi, Sara Gandini, Maria Concetta Fargnoli, et al.
International Journal of Cancer|August 1, 2014
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regionsJennifer H Barrett, John C Taylor, Chloe Bright, et al.
Pageof 5